Executive Team

Mike Doyle, FACHE, President and CEO
Mike-DoyleMike Doyle has a long track record of vision, leadership and team-building, as well as an exemplary record of creating business value in investor-backed, rapid-growth, public and private healthcare and technology companies. Prior to joining QPID, Doyle was CEO and Chairman of Medsphere Systems Corporation, developer of OpenVista, an open-source enterprise Electronic Health Record. While President and CEO of Advantedge Health Solutions, he led the rapid expansion of a hosted physician revenue cycle management solution for hospital-based physicians. As founder, CEO and President of Standish Care (CareMatrix), he was instrumental in creating the “assisted living” category. Earlier in his career he held senior leadership positions with two major integrated healthcare delivery systems: Voluntary Hospitals of America (VHA) and National Medical Enterprises (Tenet). He started his career in hospital strategy and operations at Norwood Hospital/Neponsett Valley Health System. Doyle is a Fellow in the American College of Healthcare Executives. He also holds a BS from Tufts University and a MBA from the University of Chicago in Hospital Administration and Finance where he was a Kaiser Fellow. He has been featured in many local and national publications and television programs.

Michael Zalis, MD, Co-Founder and Chief Medical Officer

Mike-Zalis-smDr. Mike Zalis is a board certified Radiologist with extensive experience and expertise in abdominal imaging, interventional radiology, computer science and clinical research. His deep knowledge of what clinicians need to practice most effectively and his ability to translate those needs into software solutions inform QPID’s development. He initiated and directed the QPID Informatics Group at MGH and is also an associate professor at Harvard Medical School. In addition to his work with QPID, Dr. Zalis continues to serve part-time with MGH Interventional Radiology. He holds a BA in Biophysics from the University of Pennsylvania and an MD from University of Virginia, and was a visiting scholar at Stanford University.

David Burke, Chief Financial Officer
David-BurkeDavid Burke combines executive skill, financial savvy and industry knowledge gained in 25 years in leadership positions in a variety of healthcare services and technology businesses.  Previously he served as COO and CFO of GNS Healthcare Inc., a big data analytics company that aids payers, providers and pharmaceutical companies with making intelligent data-driven decisions. Under David’s leadership the company established core operational, financial and administrative competencies and raised $15 million in venture funding. He was also CFO at QualityMetric, which was acquired by Ingenix, a subsidiary of UnitedHealth Group. David graduated cum laude from Harvard College and received his MBA from Columbia University Graduate School of Business.

Janine Powell, Vice President of Customer Service
Janine-PowellAs VP of Client Services, Janine Powell provides implementation, customer care and client management services to QPID’s clients.  Janine brings extensive healthcare and IT experience to QPID’s client services team, applying knowledge from client service and product roles at Encore Health Resources, Medsphere Systems Corporation, Skylight Healthcare Systems, Bridge Medical and McKesson. As a clinical project management expert, she has guided dozens of hospitals to successful EHR implementations and Meaningful Use Phase 1 attestations. A Dietitian, Janine has worked in inpatient, outpatient and private practice settings and holds a BS in Nutrition from California State University-Northridge.

Gary Zakon, Vice President of Engineering
Gary-ZakonGary Zakon is a software engineering leader, experienced at building engineering organizations and assuring product development success in both large company and startup environments. He’s been an executive team manager developing software platforms in emerging markets for companies such as Novera Software and OpenPages. He was also previously Chief Technology Officer at ModelLogic, a technology strategy consultancy focused on cloud computing and SaaS initiatives.

Jim Dowling, Vice President of Sales
Jim Dowling for websiteJim Dowling serves as Vice President of Sales and brings more than 25 years of experience in healthcare technology sales and general management to his role. Prior to joining QPID health he was the Executive Vice President of the enterprise self-service business unit at QuadraMed Corporation, where he played a key role in the sale of the company. At NCR Healthcare he was general manager and vice president of sales. Additionally, he held a variety of senior sales and management positions at GE Healthcare IT/IDX Systems, including General Manager of the imaging solutions division. Jim holds a BS in Marketing from the New York Institute of Technology.

Afik Gal, MD, Vice President of Product Innovation
afikDr. Afik Gal is an expert in healthcare analytics, digital health, and machine learning and has held a variety of product management, technical and consulting roles at the forefront of health technology innovation. He came to QPID Health from PwC’s Healthcare Innovation and Healthcare Incubation lab, where he advised clients in healthcare (both providers and payers), technology and pharma/biotech on strategy and new business models. Previously he founded and led a boutique consulting firm and a healthcare analytics startup company. He holds an MD from Ben-Gurion University in Israel and an MBA from Duke University.

Board of Directors

Mike Doyle
President and CEO

Michael Zalis, MD
Co-Founder and Chief Medical Officer

Carl Berke
Partner, Partners Innovation Fund
Carl’s career has spanned over 25 years in the practice and management of innovation to bring new technologies from lab to market. He has been an active private equity investor as a member of Angel Healthcare Investors LLC and is a founder of Mass Medical Angels. He has served on the boards of Quosa, Kasalis, Combinent, Infobionic and the Sudanese Education Fund. Carl holds an AB degree from Cornell University and received his PhD in Organic Chemistry from the University of California at Berkeley. He also holds an appointment as Lecturer in the Biomedical Enterprise Program in the Harvard-MIT Division of Health Sciences and Technology. Carl currently represents the Fund on the Boards of Annovation, Sebacia and QPID Health.

Philippe Chambon
Managing Director, New Leaf Venture Partners
Philippe Chambon is a Managing Director and concentrates on information convergence and biopharmaceutical investments. He joined the Sprout Group in 1995 and became a General Partner in 1997 before becoming one of the founders of New Leaf in 2005. Over his career, he has invested broadly in healthcare technology companies across multiple sectors and stages of development. Philippe served as Manager in the Healthcare Practice of The Boston Consulting Group from 1993 to 1995. From 1987 to 1993, he was an executive with Sandoz Pharmaceutical, where he led strategic product development, portfolio management and pre-marketing activities in his capacity as Executive Director of New Product Management. Philippe did graduate research in molecular immunology at The Pasteur Institute and earned a M.D., Ph.D. from the University of Paris. Philippe also has an M.B.A. from Columbia University in New York.

Brandon Hull
Managing General Partner, Cardinal Partners
Brandon Hull is a co-founder of Cardinal Partners, a medical and life sciences venture capital partnership established in 1996. His investment experience began in 1991 and includes all facets of health care services, medical products and devices, but he has particular range and expertise in healthcare information technology and technology-enabled-services. Brandon spent seven years in health services operations previously, and has served on the boards of numerous healthcare and medical technology companies, spanning the landscape of the healthcare economy, from insurers and managed care payers, inpatient and outpatient providers, and consumer health markets. Past and present board seats include athenahealth (ATHN), Visicu (Phillips Medical), CodeRyte (3M), Fluidnet, Novalis (Trizetto), Awarepoint and QPID Health. Brandon received his BA from Wheaton College (Chicago) and his MBA from The Wharton School at the University of Pennsylvania.

Stan Reiss

General Partner, Matrix Partners
Stan Reiss is passionate about bringing cutting edge technology to market. Since joining Matrix over a decade ago, he has invested primarily in companies developing technically sophisticated components, systems, and software, including healthcare information technology.  His investments include Acacia Communications, Fastback Networks, QPID Health, Qualtre, and Xtalic. Stan received a bachelor’s degree in electrical engineering at Cornell University, two engineering masters’ degrees from MIT (focused on communications networking), and an MBA from the Harvard Business School (where he was a Baker Scholar).

Investors

Cardinal Partners
Since 1996, Cardinal Partners has been one of the leading venture capital partnerships focused exclusively on healthcare investing. Cardinal specializes in early stage financing rounds, usually as the lead investor in the initial financing round of a growth company. Cardinal’s investors include university endowments, foundations, pension funds, banks, and insurance companies. Cardinal currently manages funds totaling $400 Million.

Massachusetts General Physicians Organization
The Massachusetts General Physicians Organization (MGPO) is a multi-specialty medical group dedicated to excellence and innovation in patient care, teaching and research.

Matrix Partners
Matrix Partners is a premier venture capital firm that has generated outstanding returns for more than three decades. By focusing on early-stage investments and emphasizing long-term relationships with entrepreneurs, the firm has delivered several of the industry’s top performing funds of all time. Matrix Partners has offices in Cambridge and Waltham, MA; Palo Alto, CA; Mumbai, India; and Beijing and Shanghai, China. Matrix Partners has invested in several game-changing, industry-leading businesses such as Apple Computer, Aruba, HubSpot, JBoss, Netezza, Phone.com, Polyvore, Starent Networks, Tivoli Systems, Veritas, Zendesk, and Zong.

New Leaf Venture Partners
New Leaf Venture Partners is a leading healthcare technology venture firm.  We invest broadly across healthcare-related information technology companies as well as both public and private biopharmaceutical companies. New Leaf currently manages two funds: New Leaf Ventures I, L.P., and New Leaf Ventures II, L.P. (NLV-II), as well as the healthcare technology portfolio of the Sprout Group, one of the oldest U.S. venture capital fund groups.  New Leaf’s current active fund, NLV-II, has committed $80 million to companies in the healthcare IT sector and $270 million to firms in the biopharmaceutical sector.  For more information please visit http://www.nlvpartners.com.

Partners Innovation Fund
The Partners Innovation Fund, established in 2007, was launched with a total commitment of $35 million from Brigham and Women’s Hospital and Massachusetts General Hospital. It addresses Partners HealthCare’s unmet need for funding of early-stage technology to drive improved medical care for patients.

Advisory Board

David W. Bates, MD, MSc, Chief of the Division of General Internal Medicine and Primary Care at Brigham and Women’s Hospital, Professor of Medicine at Harvard Medical School, and Professor of Health Policy and Management at the Harvard School of Public Health.

Alan Ezekowitz, MBChB, D.Phil., FAAP, Co-Founder, President and CEO of Abide Therapeutics

John D. Halamka, MD, MS, a Professor of Medicine at Harvard Medical School and Chief Information Officer of Beth Israel Deaconess Medical Center.

Julia Adler-Milstein, PhD, an Assistant Professor at University of Michigan whose research focuses on policy and management issues related to the use of IT in healthcare delivery.

John E. Osborn, JD, MIPP, a senior advisor with the international law firm Hogan Lovells, executive in residence with the healthcare group of Warburg Pincus, a regular contributor to Forbes.com and a faculty member at the University of Washington, Seattle.

Robert M. Wachter, MD, a Professor of Medicine at the University of California, San Francisco (UCSF), Associate Chairman of UCSF’s Department of Medicine, and Chief of UCSF’s 60-faculty Division of Hospital Medicine.